Oculis Holding AG (OCS)

NASDAQ: OCS · Real-Time Price · USD

19.16

+0.14 (0.74%)

At close: Jun 16, 2025, 4:00 PM

19.00

-0.16 (-0.84%)

After-hours: Jun 16, 2025, 4:06 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Innovative Drug	778.95K	Log In
Innovative Drug Growth	-20.72%	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending